|
Glioblastoma |
|
|
|
A. J. Newman, J. Fiveash, S.
Rosenfeld, M. Johnson, R. Diasio, W. Wang, A. Cockrell-Donohue, L. B. Nabors
A phase I study of capecitabine and concurrent
radiotherapy (RT) for patients with newly diagnosed glioblastoma multiforme
(GBM)
40th
ASCO Annual Meeting. New Orleans, LA. June 5-8, 2004. Abstract No. 1537
|
|
|
Gliomas
|
|
|
|
U.
Bogdahn, P. Hau, T. Jauch, U. Baumgart, O. Grauer, L. Kaes, H. Koch, C.
Wismeth, P. Krauseneck, A. Steinbrecher
Low-dose chemotherapy in combination with COX-2
inhibitors and PPARgamma agonists in recurrent high-grade glioma - a phase-II
study
39th ASCO Annual Meeting.
Chicago, IL. May 31-June 3, 2003. Abstract No. 473
|
|
|
Metastatic
Tumors
|
|
|
|
|
Ekenel M, Hormigo AM, Peak S, Deangelis LM,
Abrey LE.
Capecitabine therapy of central nervous system metastases from breast
cancer
J Neurooncol.
2007 Nov;85(2):223-7.
Epub 2007 Jul 5
 Abstract |
 Reprint |
DBLinks | BL 7:6
|
|
Lisa
R. Rogers, Sandra E. Remer, Sheela Tejwani
Durable response of breast cancer leptomeningeal
metastasis to capecitabine monotherapy
Neuro-Oncology, January 2004, Volume 6 Number 1, Pages 63 -- 64 (Abstract+)
|
|
|
|
